Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers
Titel:
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers
Auteur:
Walker, Logan C Fredericksen, Zachary S Wang, Xianshu Tarrell, Robert Pankratz, Vernon S Lindor, Noralane M Beesley, Jonathan Healey, Sue Chen, Xiaoqing kConFab Stoppa-Lyonnet, Dominique Tirapo, Carole Giraud, Sophie Mazoyer, Sylvie Muller, Danièle Fricker, Jean-Pierre Delnatte, Capucine GEMO Study Collaborators Schmutzler, Rita K Wappenschmidt, Barbara Engel, Christoph Schönbuchner, Ines Deissler, Helmut Meindl, Alfons Hogervorst, Frans B Verheus, Martijn Hooning, Maartje J van den Ouweland, Ans MW Nelen, Marcel R Ausems, Margreet GEM Aalfs, Cora M van Asperen, Christi J Devilee, Peter Gerrits, Monique M Waisfisz, Quinten HEBON Szabo, Csilla I ModSQuaD Easton, Douglas F Peock, Susan Cook, Margaret Oliver, Clare T Frost, Debra Harrington, Patricia Evans, D Gareth Lalloo, Fiona Eeles, Ros Izatt, Louise Chu, Carol Davidson, Rosemarie Eccles, Diana Ong, Kai-Ren Cook, Jackie EMBRACE Rebbeck, Tim Nathanson, Katherine L Domchek, Susan M Singer, Christian F Gschwantler-Kaulich, Daphne Dressler, Anne-Catharina Pfeiler, Georg Godwin, Andrew K Heikkinen, Tuomas Nevanlinna, Heli Agnarsson, Bjarni A Caligo, Maria Adelaide Olsson, Håkan Kristoffersson, Ulf Liljegren, Annelie Arver, Brita Karlsson, Per Melin, Beatrice SWE-BRCA Sinilnikova, Olga M McGuffog, Lesley Antoniou, Antonis C Chenevix-Trench, Georgia Spurdle, Amanda B Couch, Fergus J